Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 20. November 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8238  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 164744  
   
Urgent chemotherapy for advanced mediastinal malignant germ cell tumor: A case report and literature review.
Medicine (Baltimore)
Wang C, Ji Y, Xia G, Ma S.
PMID: 43063085 [PubMed - indexed for MEDLINE]


Metastatic G2 laryngeal neuroendocrine tumor treated with sulfatinib and sintilimab: A case report and literature review.
Medicine (Baltimore)
Luo Y, Mao A, Li X, Wang T, Wang J, An N.
PMID: 43063076 [PubMed - indexed for MEDLINE]


STAT3/NF-κB signaling axis in macrophage and myeloid-derived suppressor cell driven immune evasion in lung cancer.
Cell Biol Toxicol
Zhang H, Liu L, Huang Z, Guo L, Xia Y, Yang Y, Wang L, Zhang X, Wang Y, Li X.
PMID: 43062513 [PubMed - indexed for MEDLINE]


Integration of a severe immune-related adverse events predictive model with efficacy biomarkers enables precise stratification in NSCLC immunotherapy: insights from the phase 3 ORIENT-11 study.
Cancer Immunol Immunother
Peng Y, Wen L, Shen J, Zhan J, Zhou H, Liu J, Chen G, Zhang Y, Zhao S, Zhao Y, Huang Y, Fang W, Yang Y, Sun H, Zhang L, Sun D.
PMID: 43062512 [PubMed - indexed for MEDLINE]


Advances in personalized management strategies for ground-glass opacity-featured lung cancer.
J Thorac Cardiovasc Surg
Li T, Zhang Y, Chen H.
PMID: 43062399 [PubMed - as supplied by publisher]


Indocyanine Green Assists in Identification of Solid Tumor Pulmonary Metastases.
Pediatr Blood Cancer
Carter M, Bondoc AJ, Jenkins TM, Lautz TB, Ayala SA, Kastenberg ZJ, Arkin C, Malek MM, Campwala I, Aldrink JH, Horvath KZ, Piché N, Osman Y, Brown EG, Doyle K, Abril P, Roach JP, Ziogas IA, Rhee DS, Chidiac C, Polites SF, Debertin J, Craig BT, Lal DR, Kim ES, Lee WG, Barkhordar A, Le HD, Joshi D, Stellon M, Tracy ET, Beckhorn C, Davies DA, Boehmer C, Dasgupta R.
PMID: 43062150 [PubMed - as supplied by publisher]


Incidence and Risk Factors of Postoperative Delirium in Patients with Lung Cancer: A Systematic Review and Meta-Analysis.
J Vis Exp
Quan Q, Jiang H, Zhao Z, Liang X, Cao B, Wang H, Zhang X.
PMID: 43062053 [PubMed - indexed for MEDLINE]


Effect of the timing and setting of pulmonary rehabilitation on functional recovery after lung cancer surgery: A systematic review and meta-analysis.
Clin Rehabil
Zhang W, Zhou Y, Wang W, Zheng C, Cui X, Chen Y, Xu X.
PMID: 43061927 [PubMed - as supplied by publisher]


Diagnostic Challenges in Paediatric Pulmonary Mucoepidermoid Carcinoma: A Case Report.
Respirol Case Rep
Figueroa M, Chan A, Gay A, Waloff K, Lee V.
PMID: 43061243 [PubMed]


Macrophage state in neoadjuvant and perioperative immunotherapy resistance in resectable NSCLC: a critical appraisal of strategies from CSF1R and CD47-SIRPα to CAR-macrophages.
Front Immunol
Li H, Li B, Li Z, Wang Z, Sun W, Yang K, Yang Y, Wang B.
PMID: 43060940 [PubMed - indexed for MEDLINE]


Compartmental immune responses and biomarker discordance after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
Front Immunol
Han S, Ma Y, Li Z, Chen W, Xue Z, Gou Y.
PMID: 43060732 [PubMed - indexed for MEDLINE]


Development of a lung nodule volumetry tool for quality assurance assessment of low-dose lung cancer screening CT protocols.
Med Phys
Siddiki Y, Gallego Manzano L, Pozzessere C, Rotzinger DC, Racine D, Vitzthum V.
PMID: 43059108 [PubMed - indexed for MEDLINE]


An integrated radiomics-pathomics approach for predicting efficacy and prognosis of immunotherapy in advanced non-small cell lung cancer.
BMC Pulm Med
Liang Z, Zeng N, Pei M, Li C, Zhu J, Wen Z.
PMID: 43058622 [PubMed - indexed for MEDLINE]


Integrating pleural fluid and peripheral blood biomarkers to improve malignant vs. tuberculous pleural effusion diagnosis: a retrospective study.
BMC Pulm Med
Yu S, Liu F, Tian Q, Xu S, Niu C, Zhan H.
PMID: 43058578 [PubMed - indexed for MEDLINE]


A multiparametric nomogram to reduce unnecessary EBUS-TBNA in suspected lung cancer: development and internal validation in an anthracosis-prevalent cohort.
BMC Cancer
Koç A, Korkmaz C, Demirba, Vatansev H, Ata, , , Erol M, Esen HH, Zamani A.
PMID: 43058559 [PubMed - indexed for MEDLINE]


Gut microbiome and immunotherapy in advanced non-small cell lung cancer: a prospective cohort study.
BMC Cancer
Kapoor A, Chaudhary M, Gupta A, Sansar B, Mishra BK, Pal A, Thakur P, Kallapura G, Josphine I, Singh A, Upadhyay A, Sisodia N, Singh N, Shukla S, Bajpai V, Noronha V, Prabhash K.
PMID: 43058555 [PubMed - indexed for MEDLINE]


A retrospective study on neutrophil-to-lymphocyte ratio in the early treatment stage for stratifying the incidence of PD-1 inhibitor-related thyroid dysfunction.
Support Care Cancer
Liu J, Qin B, Li K, Cai L, Bai N, Zhang X, Li S, Chen M, Wang T.
PMID: 43058266 [PubMed - indexed for MEDLINE]


Robot-assisted distal right main bronchus sleeve resection with double-barrelled neo-interlobar carina reconstruction.
Multimed Man Cardiothorac Surg
Antonicelli A, Muriana P, Gargiulo C, Novellis P, Tambasco A, Tummineri R, Ferrara R, Gasparini S, Veronesi G.
PMID: 43055432 [PubMed - indexed for MEDLINE]


ERS clinical practice guidelines for the management of patients with idiopathic pulmonary fibrosis and lung cancer.
Eur Respir J
Tzouvelekis A, Hellemons ME, Billiet C, Blum TG, Cadranel J, Fabbri L, Guler SA, Guiot J, Hardavella G, Hoyer N, Jones S, Miyamoto A, Lee JS, Piciucchi S, Ricciardi S, Russell AM, Tietzova I, Tonia T, Trujillo-Reyes JC, Vancheri C, Kreuter M.
PMID: 43057869 [PubMed - as supplied by publisher]


First-in-human, phase I study of clesitamig, a DLL3-targeted CD3×4-1BB trispecific T-cell engager in patients with advanced small-cell lung cancer and other neuroendocrine carcinomas.
J Immunother Cancer
Yoshida T, Fowler S, Franjkovic I, Gochitashvili N, Lane C, Tanos T, Kraxner A, Wolowski V, Serrano-Serrano ML, About M, Lotz G, Appel LM, Takeshita H, Kozlowski C, Kadoriku M, Sasaki J, Yamagata R, Nakamura M, Liu SV, Felip E, Moreno V, Dziadziuszko R, Gutierrez M, Meador CB, Villaruz L, Rohrberg KS, Johnson ML, Paz-Ares L, Gay CM, Alahmadi A, Gadgeel SM, Cooper AJ, Cirovic O, Yoh K.
PMID: 43057868 [PubMed - in process]


   
   Artikel 1 - 20 / 164744    Seite 1 von 8238  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1